IDXG
Interpace Biosciences, Inc. Common Stock
IDXG
IDXG
Delisted
IDXG was delisted on the 24th of February, 2021.
20 hedge funds and large institutions have $6.95M invested in Interpace Biosciences, Inc. Common Stock in 2019 Q1 according to their latest regulatory filings, with 4 funds opening new positions, 7 increasing their positions, 3 reducing their positions, and 4 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
Holders
20
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$1.32M | |
| 2 | +$1.15M | |
| 3 | +$713K | |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$214K |
| 5 |
Geode Capital Management
Boston,
Massachusetts
|
+$137K |
Top Sellers
| 1 | -$320K | |
| 2 | -$60.2K | |
| 3 | -$24K | |
| 4 |
MWM
Merriman Wealth Management
Seattle,
Washington
|
-$9K |
| 5 |
Macquarie Group
Sydney, NSW 2000,
Australia
|
-$6K |